Marcus Schindler
Chief Tech/Sci/R&D Officer bij NOVO NORDISK A/S
Profiel
Marcus Schindler is Chief Scientific Officer & Executive VP-Research bij Novo Nordisk A. Hij behaalde een doctoraat aan de Universiteit van Cambridge.
Actieve functies van Marcus Schindler
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVO NORDISK A/S | Chief Tech/Sci/R&D Officer | 01-03-2021 |
Eerdere bekende functies van Marcus Schindler
| Bedrijven | Functie | Einde |
|---|---|---|
| INNATE PHARMA | Director/Board Member | 28-05-2021 |
| The Oxford | Chief Tech/Sci/R&D Officer | 29-02-2008 |
Prosidion Ltd.
 Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Chief Tech/Sci/R&D Officer | - |
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
Opleiding van Marcus Schindler
| University of Cambridge | Doctorate Degree |
| University of Gottingen | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| INNATE PHARMA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| The Oxford | Consumer Services |
Prosidion Ltd.
Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK | Health Technology |
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
